MRK Financial Facts
Restructuring costs: 545.6MMaterials and production: 5.59B
See Full Income Statement
Trade accounts payable: 646.8M
Cash and cash equivalents: 6.63B
See Full Balance Sheet
Merck & Co. Inc. (MRK) Earnings
|
Expand Research on MRK
| Next EPS Date | 4/25/24 | EPS Growth Rate | +37.9% |
|---|---|---|---|
| Average EPS % Beat Rate | +36.4% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | +2.1% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
2/3/11  |
 |
Q410 | $0.88 | $0.83 | +$0.05 | $12.1B | $11.53B | = |  | | Details |
| 10/29/10 |
|
Q310 | $0.85 | $0.82 | +$0.03 | N/A | N/A | N/A | | | Details |
| 10/28/21 | |
Q321 | $1.75 | $1.55 | +$0.20 | $13.2B | $12.33B |  |
| | Details |
| 4/28/15 |
|
Q115 | $0.85 | $0.74 | +$0.11 | $9.4B | $9.04B |  |
| | Details |
| 2/1/24 | Q423 | $0.03 | -$0.11 | +$0.14 | $14.6B | $14.47B | = | | | Details | |
| 4/28/22 | |
Q122 | $2.14 | $1.83 | +$0.31 | $15.9B | $14.71B | = | | | Details |
| 10/25/18 | |
Q318 | $1.19 | $1.12 | +$0.07 | $10.8B | $10.88B | = | | | Details |
| 4/27/23 | Q123 | $1.40 | $1.35 | +$0.05 | N/A | $13.78B | = | | | Details |
